Every 10-Q that Ambac Financial Group, Inc. (AMBC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow AMBC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AMBC filings page.
Octave Specialty Group reported much stronger first-quarter results, with total revenues rising to $104.2 million from $62.8 million a year earlier, driven mainly by Insurance Distribution commissions and fees. The company still posted a net loss attributable to shareholders of $6.9 million, but this narrowed sharply from $46.4 million.
Net loss from continuing operations improved to $2.9 million versus $14.5 million, as higher commissions and premiums more than offset increased operating and acquisition-related expenses. Insurance Distribution generated segment pretax income of $16.8 million, while Specialty Property & Casualty and Corporate & Other segments remained loss-making.
On the balance sheet, total assets were $2.27 billion and total stockholders’ equity was $833.6 million. Cash, cash equivalents and restricted cash increased to $93.5 million. Octave also reduced redeemable noncontrolling interests by buying out certain minority owners, and recorded sizable foreign currency translation losses that lowered accumulated other comprehensive income.
Ambac Financial Group (AMBC) reported Q3 2025 results. Total revenues were $66,606 (thousands) and net loss attributable to shareholders was $(112,620) (thousands), or $(2.35) per share. Continuing operations posted a net loss of $(30,838) (thousands), while discontinued operations recorded a $(80,890) (thousands) loss, which includes a $50,012 (thousands) loss on disposal.
The company completed the sale of its Legacy Financial Guarantee business (AAC) on September 29, 2025, reclassifying prior-period results to discontinued operations. Total assets were $2,147,890 (thousands) at September 30, 2025, compared with $8,058,378 (thousands) at December 31, 2024, reflecting the divestiture. Operating cash flow from continuing operations was $(51,617) (thousands); investing included $407,300 (thousands) of proceeds from a subsidiary sale, and financing included repayment of $150,000 (thousands) of short-term debt.
On October 31, 2025, Ambac acquired ArmadaCare for $250,000 (thousands) and put in place a $100,000 (thousands) term loan and a $20,000 (thousands) revolver, both fully drawn at closing. As of November 7, 2025, 43,812,035 common shares were outstanding.